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doi:10.1016/j.ejvs.2009.09.001Abstract Intramural hematoma (IMH) of the aorta and penetrating aortic ulcer (PAU) are
important variant forms of classic double-barrel aortic dissection in patients presenting with
acute aortic syndrome. Recent insights provided by modern high-resolution imaging are
currently challenging previous pathophysiologic concepts underlying IMH and PAU, suggesting
a close relationship of both entities. Thoracic endovascular aortic repair (TEVAR) offers a less
invasive approach to the treatment of affected patients with very encouraging early to
midterm results. This review discusses current indication for TEVAR in IMH and PAU patients
in the view of an improved understanding of these diseases.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Diseases of the thoracic aorta contribute significantly to the
high overall mortality from cardiovascular disease.1,2 In
recent years, advances in modern high-resolution imaging
have provided valuable insights into the pathophysiology of
aortic diseases and have identified important subforms of
classical double-barrel aortic dissection, resulting in
a better understanding of acute aortic diseases.3,4 Acute
aortic syndrome (AAS), which contrasts nicely with acute1 723 4804; fax: þ49 201 723
geb r e c h t@uk - e s s e n . de
ty for Vascular Surgery. Publishecoronary syndrome, describes patients who present with
somewhat uniform sudden chest/back pain symptoms of
sharp/tearing character (‘‘aortic pain’’), which are caused
by various acute aortic diseases.4 The subsumption of such
patients under the term ‘‘acute aortic syndrome’’ allows
for a more uniform, standardized approach to diagnosis and
management of acute aortic diseases.4
Acute aortic syndrome encompasses classic aortic
dissection with true and false-lumen (class 1 dissection
according to Svensson3) and less common variant forms or
potential precursors of classic dissection such as intramural
hematoma of the aortic wall (IMH, class 2 dissection),
subtle dissection (class 3 dissection), which is found intra-
operatively in Marfan patients, penetrating aortic ulcer
(PAU, class 4 dissection), and iatrogenic or traumatic
transsection of the aorta (class 5 dissection). In somed by Elsevier Ltd. All rights reserved.
660 H. Eggebrecht et al.patients, AAS may also be caused by symptomatic aortic
aneurysm.2,5
The aim of this review is to summarise the currently
available literature with respect to indication to endovas-
cular treatment in patients presenting with IMH or PAU.Intramural hematoma
Intramural hematoma accounts for approximately 6e10% of
all acute aortic syndromes.6,7 In Asian studies, the inci-
dence of IMH among AAS patients was significantly higher,
approximating 30e40% of patients.5,8 First described by
Krukenberg in 1920,9 IMH is commonly defined as bleeding
into the outer layers of the aortic media, presumably
caused by apoplectic rupture of aortic vasa vasorum, which
are prone to rupture due to alterations from chronic arte-
rial hypertension.1,4 By definition, IMH lacks a detectable
intimal tear/disruption, and has therefore no communica-
tion with the true aortic lumen, but is confined within the
aortic wall (‘‘dissection without intimal tear’’). On imaging
IMH is identified by crescent-shaped or concentric thick-
ening of the aortic wall, which in its early stage shows
hyper-intensity on T2 imaging by MRI or hyper-density in
non contrast-enhanced computed tomography (CT). Thus,
IMH can even be detected on a native CT scan. Luminal
displacement of intimal calcification may be helpful in
differentiating IMH from mural thrombus. In addition,
transesophageal echocardiography provides important
information for diagnosing IMH.6 Intramural hematoma may
affect the entire thoracic aorta and usually e similar to
classic dissection e involves a longer segment of the aorta.
Symptoms of IMH may be very similar to those of classic
dissection, and patients can not be reliably distinguished by
clinical presentation alone.4 However, the risk of malper-
fusion is lower with IMH and thus symptoms of organ
ischemia may be absent in IMH patients.
So far, the natural history of IMH is not fully understood.
Published data are somewhat conflicting with some
reporting a rather favorable outcome of IMH as compared
to classic dissection, whereas others have reported similar
mortality and complication rates to double-barrel dissec-
tion.5 Complications of IMH are quite common and include
progression towards overt false-lumen dissection in 28e47%
of cases, early aneurysm formation or (contained) rupture
in 20-45% of patients.7 Patients may, however, show spon-
taneous reabsorption of IMH under medical treatment,
although regression is less common. Predictors of progres-
sion include recurrent or persisting pain, and presence of
penetrating aortic ulcer, while younger age, aortic diam-
eter <4.0e4.5 cm, and hematoma thickness <1.0 cm
portend a better prognosis.4,5
Previous studies have shown that the location of the IMH
is of paramount importance for patient’s prognosis. In
analogy to the Stanford classification of classic aortic
dissection, involvement of the ascending aorta (type A-IMH)
demands urgent surgical repair in most of the patients due
to the risk of rupture or progression to frank dissection. It
should, however, be noted that in particular groups from
Japan and Korea have documented a more benign course of
type A-IMH with non-operative management, recommend-
ing primarily strict blood pressure control, prolonged bedrest (4 weeks), and close imaging surveillance.7,8 It has
been speculated that the relatively low mortality rate in
Asian IMH patients may be explained by a genetic factor or
the fact that more limited IMHs were included in these
series.7 Intramural hematoma confined to the aortic arch
or the descending thoracic aorta (type B-IMH) may
primarily be safely treated non-surgically with close
imaging follow-up.
Penetrating aortic ulcer
Penetrating aortic ulcer of the aorta has first been
described by Shennan in 1934,10 but has only recently been
acknowledged as a distinct pathologic variant of classic
false-lumen aortic dissection.11 Previous investigators have
estimated that 2.3e7.6% of acute aortic syndromes are
caused by PAU.12 Penetrating atherosclerotic ulcer is
defined by an ulceration of an aortic atherosclerotic plaque
penetrating through the internal elastic lamina into the
aortic media.11
Penetrating aortic ulcer occurs most often in patients
with extensive atherosclerotic disease.11 Therefore, usually
patients in their 7th life decade and older are affected by
PAU. Similar to IMH, patients may not be distinguished from
classic dissection by clinical presentation alone, since
symptoms may be very similar. Penetrating aortic ulcer has
a characteristic appearance on angiography, reminiscent of
duodenal ulcer. Nowadays, angiography is only rarely per-
formed to diagnose PAU, whereas non-invasive imaging
modalities, which in addition provide important informa-
tion on the tissue surrounding the aorta, are used more
frequently. On imaging, PAU typically appears as one or
more focal, contrast-material filled, craterlike out-
pouchings of the lumen, with a thickened aortic wall and
inward displacement of calcified intima by concomitant
intramural haematoma.13 Penetrating ulcers have been
described along the whole length of the aorta but most
commonly involve the mid and distal descending thoracic
aorta. There is a strong association of PAU with concomi-
tant abdominal aortic aneurysms. Penetrating ulcers of the
ascending aorta (type A PAU) are rare, but dreadful
requiring urgent surgical repair in most patients.4,13
Complications of PAU include development of (localized)
intramural hematoma due to arrosion of aortic vasa vaso-
rum by the ulcer, (pseudo)aneurysm formation, progression
to overt aortic dissection, or rupture in up to 40% of
patients.4,14e16
Again similar to IMH, the natural history of PAU is not
fully understood yet. There are conflicting data in the
literature with respect to disease behaviour.14e16 While
some authors reported PAU to be malignant,11,14e16 others
reported a lower incidence of life-threatening complica-
tions.17,18 It appears that symptomatic patients presenting
with AAS caused by PAU have a worse prognosis than those
who are asymptomatic and PAU is found incidentally on
axial imaging.
Recent insights into IMH and PAU
The rigorous classic definition of IMH as being a ‘‘dissection
without a tear’’ has long been doubted by several
Indications in IMH and PAU 661investigators postulating the presence of an intimal tear/
disruption that may be not detectable with previously
available imaging modalities (Fig. 1). Moreover, it appears
that IMH and PAU may not only be distinct entities, but
there may be a considerable overlap between both. This
controversy highlights that e at present e both patho-
physiology and natural history of IMH and PAU are not fully
understood.
Recent observations from the Vienna group have chal-
lenged the classical hypothesis of IMH being a dissection
without a tear.19 Michael Grimm has provided important
novel insights into mechanisms underlying IMH of the entire
aorta.19 Grimm et al. detected small atherosclerotic plaque
ruptures at the free lateral wall or at the concavity of the
aortic arch as the cause of IMH in 8 previously unrecognised
patients with IMH involving the entire aorta (including
ascending aorta). Detection of these discrete lesions was
accomplished by the use of modern high-resolution ECG-
gated CT angiography, applying mulitplanar reconstructions
in parasagital orientation. They found that if the ulcer is at
the convexity of the distal arch, supra-aortic branchesFigure 1 Aþ B. IMH (asterisk) with plaque ulceration/intimal disr
in a patient with acute aortic syndrome. Cþ D. Complete reabsorpprevent retrograde extension toward the ascending aorta.19
Conversely, if the ulceration site is found at the free lateral
wall or at the concavity of the arch, IMH may extend ret-
rogradly into the ascending aorta, as well as antegradly into
the descending aorta. Consequently following their
hypothesis, Grimm et al.19 used the ulceration site as the
landing zone for thoracic aortic endovascular repair
(TEVAR). Most interestingly, they observed resorption of
IMH especially within the ascending aorta in all patients,
although the stent-graft was placed in the distal arch
(Fig. 2).
Grimm et al.19 suggested that rupture of a small
atherosclerotic plaque may be the underlying mechanism of
IMH formation in their patients, which deserves further
discussion. As highlighted above, PAU may indeed lead to
IMH due to arrosion of vasa vasorum, which is observed in
many PAU cases; however, in its classical sense this type of
IMH is thought to be segmental and may thus not affect the
entire aorta. One could therefore also hypothesize that the
ulceration site as detected by Grimm et al.19 is caused by
the wall hematoma resulting in high pressure within theuption (arrow) in the mid part of the descending thoracic aorta
tion of the IMH 1 year after TEVAR.
Figure 2 A. Contrast-enhanced CT of a patient presenting with acute aortic syndrome showing type A-IMH (asterisk) with evolving
dissection in the descending aorta. B. Multiplanar reconstruction of the CT in parasagittal orientation delineates small intimal
disruption/plaque rupture as the initial site of the IMH (arrow, asterisk-IMH). C. Transesophageal echocardiography showing active
bleeding from the aortic lumen into the hematoma (arrow). D. Result after TEVAR with stent-implantation into the distal arch. Note
complete reabsorption of the type A-IMH, as well as near-total resolution of descending thoracic aortic IMH. E. TEVAR result shown
by intraoperative TEE, showing elimination of flow into the IMH.
662 H. Eggebrecht et al.aortic wall, leading to secondary intimal disruption, rather
than a primary rupture of an atherosclerotic plaque from
the aortic lumen into the wall, subsequently leading to
antegrade or retrograde extension of the hematoma by the
high-pressure blood stream. This may be furtherFigure 3 A. Penetrating aortic ulcer (arrow) in an acute aortic
glucose metabolism within the PAU (arrow). C. Progression towards
D. Result after TEVAR with complete resolution of the ulcer.corroborated by the clinical observation that advanced
calcific atherosclerosis in IMH e similar to patients with
classic dissection e is a somewhat rare finding. Further
improvements in imaging techniques will hopefully help to
better understand the relationship between IMH and PAUsyndrome patient. B. Fused PET-CT image showing increased
pseudoaneurysm formation (arrow) under medical treatment.
Table 1. Overview of other published studies on TEVAR in PAU patients.
Authors n Technical success Complete sealing
of PAU
Neurologic
complications
In-hospital
mortality
Additional endovascular
procedures required
Aorta-related
mortality during
follow-up
Mean duration of
follow-up (months)
Dake et al. 1994 5 5/5 (100%) Not specified 0 0 0 0 11,6
Murgo et al. 1998 4 4/4 (100%) 3/4 (75%) 1 (25%) 1 (25%) 1 (25%) 1 (25%) 7,7
Brittenden et al. 1999 2 2/2 (100%) 2/2 (100%) 0 0 0 0 12
Maruyama et al. 2000 1 1/1 (100%) 1/1 (100%) 0 1 (100%) 0 Not specified Not specified
Sailer et al. 2001 4 4/4 (100%) 4/4 (100%) 0 0 0 0 8,5
Haulon et al. 2002 2 2/2 (100%) Not specified 0 0 Not specified 0 7,3
Pitton et al. 2002 1 1/1 (100%) 1/1 (100%) 0 0 0 0 12
Schoder et al. 2002 8 8/8 (100%) 8/8 (100%) 1 (13%) 0 0 1 (12.5%) 14,1
Kos et al. 2002 10 10/10 (100%) 9/10 (90%) 1 (10%) 0 1 (10%) 0 9
Faries et al. 2002 1 1/1 (100%) 1/1 (100%) 0 0 0 0 18
Ganaha et al. 2002 6 6/6 (100%) 6/6 (100%) 0 1 (17%) Not specified Not specified Not specified
Eggebrecht et al. 2003 10 10/10 (100%) 9/10 (90%) 0 0 1 (10%) 0 24,4
Crane et al. 2003 1 1/1 (100%) 1/1 (100%) 0 0 0 0 12
Demers et al. 2004 26 26/27 (100%) 24/26 (92%) 2 (8%) 3 (12%) 1 (4%) 1 (4%) Not specified
Eggebrecht et al. 2005 22 21/22 (96%) 21/22 (96%) 1 (5%) 0 1 (5%) 0 27
Brinster et al. 2006 21 21/21 (100%) 21/21 (100%) 0 0 Not specified 0 14,4
Dalainas et al. 2007 18 18/18 (100%) 18/18 (100%) 0 0 0 0 Not specified
Botta et al. 2008 19 18/19 (95%) Not specified 0 2 (11%) 0 0 22
Geisbu¨sch et al. 2008 48 45/48 (94%) Not specified 2 (4%) 7 (15%) 4 (9%) 0 Not specified
Total 209 204/209 (98%) 129/135 (96%) 8 (4%) 15 (7%) 9 (5%) 3 (2%) 14,3
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664 H. Eggebrecht et al.and provide a better understanding of the underlying
pathophysiologic mechanisms.
Ganaha et al.20 have also addressed this overlap of IMH
and PAU, highlighting substantial differences in the clinical
features and the patients’ prognoses in patients with an
IMH caused by PAU and those with an IMH not associated
with a PAU. They retrospectively analysed 65 symptomatic
patients with IMH. Patients in whom IMH was found to be
associated with PAU had a significantly worse prognosis
than those with IMH unaccompanied by PAU.20 The rate of
progression was 48% in patients with IMH and PAU and only
8% in patients with IMH alone. Interestingly, Ganaha et al.20
identified persistent or recurrent pain despite aggressive
treatment and an interval increase of pleural effusion as
clinical predictors of disease progression. As for the impli-
cations of initial PAU size, maximum diameter (>20 mm at
initial measurement) and depth (>10 mm) both correlated
significantly with disease progression.20Current indications for TEVAR in IMH and PAU
Current indications for TEVAR in type B-IMH in general cover
patients with disease progression or evolving complications
such as overt dissection and (contained) rupture or patients
unresponsive to antihypertensive treatment (i.e. persistent
chest pain).2 The observations of Grimm et al.19 have
provided the pathophysiologic basis for implantation of
covered stent-grafts into the aorta affected by IMH. In
general, long stent-grafts with a length of 20e25 cm should
be preferred in order to cover additional intimal disruption
sites. High-resolution imaging using multi-detector CT
angiography with MPR reconstructions is paramount in all
IMH patients in order to detect even discrete lesions, which
feed the hematoma. As these lesions are frequently located
in the distal arch, care must be taken to place the stent-
graft proximal within the arch so that it covers the
ulceration/disruption site. This may require intentional
overstenting of the ostium of the left subclavian artery,
which mandates prior evaluation of cerebral and vertebral
arteries before the procedure. It is an interesting clinical
observation, which is not supported by currently published
literature, that most IMH patients with refractory pain will
be pain-free after a TEVAR procedure. In the view of the
Grimm findings, it is further tempting to speculate that
TEVAR may also be applied for patients with IMH affecting
the ascending aorta (Fig. 2) in lieu of surgical repair.
However, this requires further multi-center studies due to
the small number of patients in the individual institutions
and can not be recommended routinely at this point in
time.
For PAU, so far no generally accepted therapeutic
regimen has been established.13,21 Initially asymptomatic
patients with incidental PAU finding are followed with
further imaging. Initially symptomatic but stable patients
with involvement of the descending aorta (type B-PAU) may
be managed conservatively with tight blood pressure
control, if pain at initial presentation resolves with medical
therapy and there is no radiological evidence of deterio-
ration during short-term follow-up. Close clinical and
imaging follow-up is, however, mandatory. A more aggres-
sive therapeutic approach is advocated in symptomatichigh-risk patients. In this regard, the presence of pain at
admission and the diameter of the involved aortic segment
are important predictors of aortic rupture; but rupture may
still occur in normal-sized aortas. Unrelenting or recurrent
pain and/or interval increase in pleural effusion have also
been identified as predictors of disease progression.20
Recent data suggest that evaluation of inflammation
accompanying acute aortic syndrome by PET-CT may help
to identify patients at risk for disease progression (Fig. 3).22
Given the segmental nature, PAU has been considered an
‘‘ideal’’ target which can be completely excluded with
a single piece stent-graft.13 However, patients are usually
elderly with advanced atherosclerosis which may entail
difficult vascular access as well arch disease increasing the
risk of embolic stroke during the procedure.5,13 So far
available results of TEVAR in type B-PAU are very encour-
aging (Table 1), supporting its use in patients with compli-
cations of PAU such as pseudoaneurysm formation or
(contained) rupture.
Conclusion
Intramural hematoma and penetrating ulcers are important
variant forms of classic aortic dissection. There is currently
evolving evidence that both entities may not be distinct
diseases, but there may be considerable overlap in the
pathophysiology of both. Recent studies highlighted that an
ulceration or intimal disruption site is often detected in IMH
patients, when modern high-resolution imaging techniques
with profound post-processing are used. This may provide an
adequate target for a TEVAR procedure which is currently
indicated in patients with progression of IMH towards overt
dissection or (contained) rupture. Similarly, TEVAR is indi-
cated in symptomatic patients with PAU complicated by
pseudoaneurysm formation or rupture. Future studies will
hopefully help to gain a better understanding of these
important causes of acute aortic syndrome.
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